|
1
|
Calzado MA, Renner F, Roscic A, et al:
HIPK2: a versatile switchboard regulating the transcription
machinery and cell death. Cell Cycle. 6:139–143. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Grimm M, Krimmel M, Alexander D, et al:
Prognostic value of histamine H1 receptor expression in oral
squamous cell carcinoma. Clin Oral Investig. 17:949–955. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hanken H, Gröbe A, Cachovan G, et al:
CCND1 amplification and cyclin D1 immunohistochemical expression in
head and neck squamous cell carcinomas. Clin Oral Investig.
18:269–276. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Angadi PV and Krishnapillai R: Cyclin D1
expression in oral squamous cell carcinoma and verrucous carcinoma:
correlation with histological differentiation. Oral Surg Oral Med
Oral Pathol Oral Radiol Endod. 103:e30–e35. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fracchiolla NS, Pruneri G, Pignataro L, et
al: Molecular and immunohistochemical analysis of the bcl-1/cyclin
D1 gene in laryngeal squamous cell carcinomas: correlation of
protein expression with lymph node metastases and advanced clinical
stage. Cancer. 79:1114–1121. 1997. View Article : Google Scholar
|
|
6
|
Bedewy AM, Mostafa MH, Saad AA, et al:
Association of cyclin D1 A870G polymorphism with two malignancies:
acute lymphoblastic leukemia and breast cancer. J BUON. 18:227–238.
2013.PubMed/NCBI
|
|
7
|
Shi XY, Bhagwandeen B and Leong AS: p16,
cyclin D1, Ki-67, and AMACR as markers for dysplasia in Barrett
esophagus. Appl Immunohistochem Mol Morphol. 16:447–452. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Parekh P, Motiwale L, Naik N, et al:
Downregulation of cyclin D1 is associated with decreased levels of
p38 MAP kinases, Akt/PKB and Pak1 during chemopreventive effects of
resveratrol in liver cancer cells. Exp Toxicol Pathol. 63:167–173.
2011. View Article : Google Scholar
|
|
9
|
Chen L, Wei T, Si X, et al: Lysine
acetyltransferase GCN5 potentiates the growth of non-small cell
lung cancer via promotion of E2F1, cyclin D1, and cyclin E1
expression. J Biol Chem. 288:14510–14521. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chrysovergis A, Gorgoulis VG, Giotakis I,
et al: Simultaneous over activation of EGFR, telomerase (h TERT),
and cyclin D1 correlates with advanced disease in larynx squamous
cell carcinoma: a tissue microarray analysis. Med Oncol.
28:871–877. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fristrup N, Birkenkamp-Demtröder K,
Reinert T, et al: Multicenter validation of cyclin D1, MCM7,
TRIM29, and UBE2C as prognostic protein markers in
non-muscle-invasive bladder cancer. Am J Pathol. 182:339–349. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bae DS, Cho SB, Kim YJ, et al: Aberrant
expression of cyclin D1 is associated with poor prognosis in early
stage cervical cancer of the uterus. Gynecol Oncol. 81:341–347.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cao W, Liu Y, Zhang H, Wang S, et al:
Expression of LMP-1 and cyclin D1 protein is correlated with an
unfavorable prognosis in nasal type NK/T cell lymphoma. Mol Med
Rep. 1:363–368. 2008.PubMed/NCBI
|
|
14
|
Liang SB, Furihata M, Takeuchi T, et al:
Overexpression of cyclin D1 in nonmelanocytic skin cancer. Virchows
Arch. 436:370–376. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Saida T, Koga H and Uhara H: Key points in
dermoscopic differentiation between early acral melanoma and acral
nevus. J Dermatol. 38:25–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Saawarn S, Astekar M, Saawarn N, et al:
Cyclin D1 expression and its correlation with histopathological
differentiation in oral squamous cell carcinoma.
ScientificWorldJournal. 2012:9783272012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dicker T, Siller G and Saunders N:
Molecular and cellular biology of basal cell carcinoma. Australas J
Dermatol. 43:241–246. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lu X, Du J, Liang J, et al:
Transcriptional regulatory network for psoriasis. J Dermatol.
40:48–53. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Fernández-Hernández R, Rafel M, Fusté NP,
et al: Cyclin D1 localizes in the cytoplasm of keratinocytes during
skin differentiation and regulates cell-matrix adhesion. Cell
Cycle. 12:2510–2517. 2013.PubMed/NCBI
|
|
20
|
Todd R, Hinds PW, Munger K, et al: Cell
cycle dysregulation in oral cancer. Crit Rev Oral Biol Med.
13:51–61. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Müller W, Noguchi T, Wirtz HC, et al:
Expression of cell-cycle regulatory proteins cyclin D1, cyclin E,
and their inhibitor p21 WAF1/CIP1 in gastric cancer. J Pathol.
189:186–193. 1999.
|
|
22
|
Rodriguez-Puebla ML, LaCava M and Conti
CJ: Cyclin D1 overexpression in mouse epidermis increases
cyclin-dependent kinase activity and cell proliferation in vivo but
does not affect skin tumor development. Cell Growth Differ.
10:467–472. 1999.PubMed/NCBI
|
|
23
|
Elsheikh S, Green AR, Aleskandarany MA, et
al: CCND1 amplification and cyclin D1 expression in breast cancer
and their relation with proteomic subgroups and patient outcome.
Breast Cancer Res Treat. 109:325–335. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Holst F, Stahl PR, Ruiz C, Hellwinkel O,
et al: Estrogen receptor alpha (ESR1) gene amplification is
frequent in breast cancer. Nat Genet. 39:655–660. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huang K, Huan C, Shan K, et al:
Significance of PC cell-derived growth factor and cyclin D1
expression in cutaneous squamous cell carcinoma. Clin Exp Dermatol.
37:411–417. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Scantlebury JB, Luo J, Thorstad WL, et al:
Cyclin D1-a prognostic marker in oropharyngeal squamous cell
carcinoma that is tightly associated with high-risk human
papillomavirus status. Hum Pathol. 44:1672–1680. 2013. View Article : Google Scholar : PubMed/NCBI
|
